[NLSP] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[NLSP] NLS Pharmaceutics AG
Announcement Date
15-May-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 99.93%
YoY- 99.94%
Quarter Report
NLSP's Result
NLSP's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,036 -5 -7,613 -7,855 -8,641 -7,343 -4,603 -23.78%
Tax 0 -0 -0 -0 -0 0 -0 -
NP -2,036 -5 -7,613 -7,855 -8,641 -7,343 -4,603 -23.78%
Tax Rate - - - - - - - -
Total Cost 2,036 5 7,613 7,855 8,641 7,343 4,603 -23.78%
Ratio Analysis
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
EPS 0.00 -0.14 -0.20 -0.29 -0.54 -0.50 -0.42 -
EPS Diluted 0.00 -0.14 -0.20 -0.29 -0.54 -0.50 -0.42 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.